Exscientia Plc - American Depositary Shares (NQ:EXAI)

4.840 UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 19, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exscientia Plc - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

The Law Offices of Frank R. Cruz Announces Investigation of Exscientia p.l.c. (EXAI) on Behalf of Investors

May 02, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Exscientia plc (EXAI)

April 30, 2024

From Robbins LLP

Via GlobeNewswire

EXSCIENTIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Exscientia plc. and Encourages Investors to Contact the Firm

April 29, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Exscientia Earnings Preview ↗

March 20, 2024

Via Benzinga

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia

April 29, 2024

From Faruqi & Faruqi LLP

Via GlobeNewswire

EXSCIENTIA PLC (NASDAQ: EXAI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Exscientia plc

April 29, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

ROSEN, A TOP RANKED LAW FIRM, Encourages Exscientia plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EXAI

April 29, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to Contact the Firm

April 28, 2024

From Schall Law

Via GlobeNewswire

The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD ↗

April 15, 2024

The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.

Via Talk Markets

Topics Artificial Intelligence

Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 03, 2024

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...

Via Benzinga

Six Of Seven AI Stock Categories Increased This Week ↗

March 23, 2024

All but one of the 7 artificial intelligence stock categories that I analyze weekly increased in value this week. But two categories are still down MTD, suggesting that the surge in the artificial...

Via Talk Markets

Topics Artificial Intelligence

EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023 ↗

March 21, 2024

EXAI stock results show that Exscientia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 21, 2024

Via Benzinga

Exscientia Business and Financial Update for the Full Year 2023

March 21, 2024

From Exscientia plc

Via Business Wire

Exscientia to Report Full Year 2023 Financial Results on March 21, 2024

March 14, 2024

From Exscientia plc

Via Business Wire

The Top 3 Healthcare Stocks to Buy on Weakness in 2024 ↗

March 04, 2024

Many healthcare stocks have extremely bright outlooks and very low valuations. Here are three top healthcare stocks to buy.

Via InvestorPlace

Earnings Scheduled For March 21, 2024 ↗

March 21, 2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD ↗

March 04, 2024

Grand View Research says the global

Via Talk Markets

Exscientia to Present at Upcoming Investor Conferences in March

February 28, 2024

From Exscientia plc

Via Business Wire

Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

February 26, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics ↗

February 19, 2024

The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.

Via Talk Markets

Topics Artificial Intelligence

AI Drug Hunter Firm Exscientia Fires Its CEO Over 'Inappropriate' Relationships with Two Employees ↗

February 13, 2024

Exscientia terminates CEO Andrew Hopkins over inappropriate relationships with employees. Interim CEO appointed.

Via Benzinga

Topics Artificial Intelligence

Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 13, 2024

Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 12, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 12, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers worth reading about for Monday morning!

Via InvestorPlace

Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients

February 07, 2024

From Exscientia plc

Via Business Wire

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 ↗

January 02, 2024

Lower interest rates and the low valuation of many biotech stocks are likely to result in many drug maker stocks being acquired in 2024.

Via InvestorPlace

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.